trending Market Intelligence /marketintelligence/en/news-insights/trending/QEodmqpmxXAMReCmGuIiHA2 content
Log in to other products

Login to Market Intelligence Platform


Looking for more?

Contact Us

Request a Demo

You're one step closer to unlocking our suite of comprehensive and robust tools.

Fill out the form so we can connect you to the right person.

If your company has a current subscription with S&P Global Market Intelligence, you can register as a new user for access to the platform(s) covered by your license at Market Intelligence platform or S&P Capital IQ.

  • First Name*
  • Last Name*
  • Business Email *
  • Phone *
  • Company Name *
  • City *
  • We generated a verification code for you

  • Enter verification Code here*

* Required

In this list

Robotics-maker Corindus picks up $4.8M in additional private placement closing

Street Talk Episode 56 - Latest bank MOE shows even the strong need scale to thrive

South State CenterState MOE Shows Even The Strong Need Scale To Thrive

Talking Bank Stocks, Playing The M&A Trade With Longtime Investor

Report: Kashkari Says Fed In Holding Pattern But Rate Cut Still Possible

Robotics-maker Corindus picks up $4.8M in additional private placement closing

Corindus Vascular Robotics Inc. has added about $4.8 million to the final tally of a previously announced private placement after select existing investors purchased additional shares.

Waltham, Mass.-based Corindus, a developer of vascular robotics, closed a private placement of common shares that raised approximately $14.8 million in February. The company said in a March 12 release that an additional closing has since been held, and 3,512,124 additional shares were purchased by existing investors at the original placement price of $1.38 apiece and under the same terms.

The extra closing has brought the final tally of the placement to about $19.5 million, according to Corindus. Funds from the placement are to be used for general corporate purposes.

Investors participating in the additional closing include Hudson Executive Capital LP and BioStar Ventures LLC.